| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.03 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |